{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:48:03Z","timestamp":1792741683324,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T00:00:00Z","timestamp":1292976000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00213-010-2140-0","type":"journal-article","created":{"date-parts":[[2010,12,21]],"date-time":"2010-12-21T05:46:47Z","timestamp":1292910407000},"page":"509-520","source":"Crossref","is-referenced-by-count":41,"title":["Antidepressant response to chronic citalopram treatment in eight inbred mouse strains"],"prefix":"10.1007","volume":"213","author":[{"given":"Jianwei","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Nitzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios G.","family":"Doukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariel P.","family":"Seiglie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie C.","family":"Dulawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,22]]},"reference":[{"key":"2140_CR1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00213-002-1147-6","volume":"163","author":"P Bech","year":"2002","unstructured":"Bech P, Tanghoj P, Andersen HF, Overo K (2002) Citalopram dose\u2013response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression. Psychopharmacology (Berl) 163:20\u201325","journal-title":"Psychopharmacology (Berl)"},{"key":"2140_CR2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","volume":"7","author":"O Berton","year":"2006","unstructured":"Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7:137\u2013151","journal-title":"Nat Rev Neurosci"},{"key":"2140_CR3","first-page":"241","volume":"25","author":"K Bezchlibnyk-Butler","year":"2000","unstructured":"Bezchlibnyk-Butler K, Aleksic I, Kennedy SH (2000) Citalopram\u2014a review of pharmacological and clinical effects. J Psychiatry Neurosci 25:241\u2013254","journal-title":"J Psychiatry Neurosci"},{"key":"2140_CR4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0924-977X(02)00173-6","volume":"13","author":"P Blier","year":"2003","unstructured":"Blier P (2003) The pharmacology of putative early-onset antidepressant strategies. Eur Neuropsychopharmacol 13:57\u201366","journal-title":"Eur Neuropsychopharmacol"},{"key":"2140_CR5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00176837","volume":"94","author":"F Borsini","year":"1988","unstructured":"Borsini F, Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl) 94:147\u2013160","journal-title":"Psychopharmacology (Berl)"},{"key":"2140_CR6","first-page":"275","volume":"30","author":"M Bourin","year":"2005","unstructured":"Bourin M, Masse F, Hascoet M (2005) Evidence for the activity of lamotrigine at 5-HT(1A) receptors in the mouse forced swimming test. J Psychiatry Neurosci 30:275\u2013282","journal-title":"J Psychiatry Neurosci"},{"key":"2140_CR7","doi-asserted-by":"crossref","first-page":"8165","DOI":"10.1523\/JNEUROSCI.1816-05.2005","volume":"25","author":"L Cervo","year":"2005","unstructured":"Cervo L, Canetta A, Calcagno E, Burbassi S, Sacchetti G, Caccia S, Fracasso C, Albani D, Forloni G, Invernizzi RW (2005) Genotype-dependent activity of tryptophan hydroxylase-2 determines the response to citalopram in a mouse model of depression. J Neurosci 25:8165\u20138172","journal-title":"J Neurosci"},{"key":"2140_CR8","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0022-3565(24)39013-5","volume":"295","author":"JF Cryan","year":"2000","unstructured":"Cryan JF, Lucki I (2000) Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine(2C) receptors. J Pharmacol Exp Ther 295:1120\u20131126","journal-title":"J Pharmacol Exp Ther"},{"key":"2140_CR9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","volume":"23","author":"JF Cryan","year":"2002","unstructured":"Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238\u2013245","journal-title":"Trends Pharmacol Sci"},{"key":"2140_CR10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-005-0093-5","volume":"182","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Page ME, Lucki I (2005) Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology (Berl) 182:335\u2013344","journal-title":"Psychopharmacology (Berl)"},{"key":"2140_CR11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","volume":"121","author":"MJ Detke","year":"1995","unstructured":"Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121:66\u201372","journal-title":"Psychopharmacology (Berl)"},{"key":"2140_CR12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1037\/1064-1297.5.2.107","volume":"5","author":"MJ Detke","year":"1997","unstructured":"Detke MJ, Johnson J, Lucki I (1997) Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol 5:107\u2013112","journal-title":"Exp Clin Psychopharmacol"},{"key":"2140_CR13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00004850-198707000-00005","volume":"2","author":"H Dufour","year":"1987","unstructured":"Dufour H, Bouchacourt M, Thermoz P, Viala A, Phak Rop P, Gouezo F, Durand A, Hopfner Petersen HE (1987) Citalopram\u2014a highly selective 5-HT uptake inhibitor\u2014in the treatment of depressed patients. Int Clin Psychopharmacol 2:225\u2013237","journal-title":"Int Clin Psychopharmacol"},{"key":"2140_CR14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neubiorev.2005.03.017","volume":"29","author":"SC Dulawa","year":"2005","unstructured":"Dulawa SC, Hen R (2005) Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci Biobehav Rev 29:771\u2013783","journal-title":"Neurosci Biobehav Rev"},{"key":"2140_CR15","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.npp.1300433","volume":"29","author":"SC Dulawa","year":"2004","unstructured":"Dulawa SC, Holick KA, Gundersen B, Hen R (2004) Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29:1321\u20131330","journal-title":"Neuropsychopharmacology"},{"key":"2140_CR16","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00259-005-1912-y","volume":"32","author":"K Erlandsson","year":"2005","unstructured":"Erlandsson K, Sivananthan T, Lui D, Spezzi A, Townsend CE, Mu S, Lucas R, Warrington S, Ell PJ (2005) Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: a SPECT validation study. Eur J Nucl Med Mol Imaging 32:1329\u20131336","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2140_CR17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0278-5846(82)80181-4","volume":"6","author":"K Fredricson Overo","year":"1982","unstructured":"Fredricson Overo K (1982a) Kinetics of citalopram in man; plasma levels in patients. Prog Neuropsychopharmacol Biol Psychiatry 6:311\u2013318","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2140_CR18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0278-5846(82)80180-2","volume":"6","author":"K Fredricson Overo","year":"1982","unstructured":"Fredricson Overo K (1982b) Kinetics of citalopram in test animals; drug exposure in safety studies. Prog Neuropsychopharmacol Biol Psychiatry 6:297\u2013309","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2140_CR19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0031-9384(92)90173-Y","volume":"51","author":"KS Gannon","year":"1992","unstructured":"Gannon KS, Smith JC, Henderson R, Hendrick P (1992) A system for studying the microstructure of ingestive behavior in mice. Physiol Behav 51:515\u2013521","journal-title":"Physiol Behav"},{"key":"2140_CR20","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/sj.mp.4001712","volume":"10","author":"HA Garriock","year":"2005","unstructured":"Garriock HA, Allen JJ, Delgado P, Nahaz Z, Kling MA, Carpenter L, Burke M, Burke W, Schwartz T, Marangell LB, Husain M, Erickson RP, Moreno FA (2005) Lack of association of TPH2 exon XI polymorphisms with major depression and treatment resistance. Mol Psychiatry 10:976\u2013977","journal-title":"Mol Psychiatry"},{"key":"2140_CR21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2008.07.031","volume":"594","author":"S Guzzetti","year":"2008","unstructured":"Guzzetti S, Calcagno E, Canetta A, Sacchetti G, Fracasso C, Caccia S, Cervo L, Invernizzi RW (2008) Strain differences in paroxetine-induced reduction of immobility time in the forced swimming test in mice: role of serotonin. Eur J Pharmacol 594:117\u2013124","journal-title":"Eur J Pharmacol"},{"key":"2140_CR22","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.npp.1301399","volume":"33","author":"KA Holick","year":"2008","unstructured":"Holick KA, Lee DC, Hen R, Dulawa SC (2008) Behavioral effects of chronic fluoxetine in BALB\/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology 33:406\u2013417","journal-title":"Neuropsychopharmacology"},{"key":"2140_CR23","doi-asserted-by":"crossref","first-page":"e6797","DOI":"10.1371\/journal.pone.0006797","volume":"4","author":"G Honig","year":"2009","unstructured":"Honig G, Jongsma ME, van der Hart MC, Tecott LH (2009) Chronic citalopram administration causes a sustained suppression of serotonin synthesis in the mouse forebrain. PLoS ONE 4:e6797","journal-title":"PLoS ONE"},{"key":"2140_CR24","doi-asserted-by":"crossref","first-page":"478","DOI":"10.20452\/pamw.743","volume":"119","author":"AM Koenig","year":"2009","unstructured":"Koenig AM, Thase ME (2009) First-line pharmacotherapies for depression\u2014what is the best choice? Pol Arch Med Wewn 119:478\u2013486","journal-title":"Pol Arch Med Wewn"},{"key":"2140_CR25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/bjp.2008.243","volume":"155","author":"M Kreilgaard","year":"2008","unstructured":"Kreilgaard M, Smith DG, Brennum LT, Sanchez C (2008) Prediction of clinical response based on pharmacokinetic\/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice. Br J Pharmacol 155:276\u2013284","journal-title":"Br J Pharmacol"},{"key":"2140_CR26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130100694","volume":"155","author":"I Lucki","year":"2001","unstructured":"Lucki I, Dalvi A, Mayorga AJ (2001) Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl) 155:315\u2013322","journal-title":"Psychopharmacology (Berl)"},{"key":"2140_CR27","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1176\/appi.ajp.158.11.1843","volume":"158","author":"JH Meyer","year":"2001","unstructured":"Meyer JH, Wilson AA, Ginovart N, Goulding V, Hussey D, Hood K, Houle S (2001) Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. Am J Psychiatry 158:1843\u20131849","journal-title":"Am J Psychiatry"},{"key":"2140_CR28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-4347(00)80362-X","volume":"227","author":"E Oyehaug","year":"1982","unstructured":"Oyehaug E, Ostensen ET, Salvesen B (1982) Determination of the antidepressant agent citalopram and metabolites in plasma by liquid chromatography with fluorescence detection. J Chromatogr 227:129\u2013135","journal-title":"J Chromatogr"},{"key":"2140_CR29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1017\/S0033291703001181","volume":"34","author":"G Parker","year":"2004","unstructured":"Parker G, Hadzi-Pavlovic D (2004) Is the female preponderance in major depression secondary to a gender difference in specific anxiety disorders? Psychol Med 34:461\u2013470","journal-title":"Psychol Med"},{"key":"2140_CR30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00464566","volume":"77","author":"OL Pedersen","year":"1982","unstructured":"Pedersen OL, Kragh-Sorensen P, Bjerre M, Overo KF, Gram LF (1982) Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect\u2014a phase II study. Psychopharmacology (Berl) 77:199\u2013204","journal-title":"Psychopharmacology (Berl)"},{"key":"2140_CR31","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1101\/gr.2825804","volume":"14","author":"PM Petkov","year":"2004","unstructured":"Petkov PM, Ding Y, Cassell MA, Zhang W, Wagner G, Sargent EE, Asquith S, Crew V, Johnson KA, Robinson P, Scott VE, Wiles MV (2004) An efficient SNP system for mouse genome scanning and elucidating strain relationships. Genome Res 14:1806\u20131811","journal-title":"Genome Res"},{"key":"2140_CR32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.npp.1301574","volume":"33","author":"C Pittenger","year":"2008","unstructured":"Pittenger C, Duman RS (2008) Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33:88\u2013109","journal-title":"Neuropsychopharmacology"},{"key":"2140_CR33","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Th\u00e9r 229:327\u2013336","journal-title":"Arch Int Pharmacodyn Th\u00e9r"},{"key":"2140_CR34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-2999(79)90366-2","volume":"57","author":"RD Porsolt","year":"1979","unstructured":"Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfre M (1979) Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 57:201\u2013210","journal-title":"Eur J Pharmacol"},{"key":"2140_CR35","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1471-4159.2005.03604.x","volume":"96","author":"SA Sakowski","year":"2006","unstructured":"Sakowski SA, Geddes TJ, Kuhn DM (2006) Mouse tryptophan hydroxylase isoform 2 and the role of proline 447 in enzyme function. J Neurochem 96:758\u2013765","journal-title":"J Neurochem"},{"key":"2140_CR36","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","volume":"301","author":"L Santarelli","year":"2003","unstructured":"Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805\u2013809","journal-title":"Science"},{"key":"2140_CR37","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.pnpbp.2009.02.020","volume":"33","author":"SJ Tsai","year":"2009","unstructured":"Tsai SJ, Hong CJ, Liou YJ, Yu YW, Chen TJ, Hou SJ, Yen FC (2009) Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response. Prog Neuropsychopharmacol Biol Psychiatry 33:637\u2013641","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2140_CR38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/FPC.0b013e3282fb02cb","volume":"18","author":"MV Tzvetkov","year":"2008","unstructured":"Tzvetkov MV, Brockmoller J, Roots I, Kirchheiner J (2008) Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment. Pharmacogenet Genomics 18:495\u2013506","journal-title":"Pharmacogenet Genomics"},{"key":"2140_CR39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10519-009-9325-5","volume":"40","author":"L Velez","year":"2009","unstructured":"Velez L, Sokoloff G, Miczek KA, Palmer AA, Dulawa SC (2009) Differences in aggressive behavior and DNA copy number variants between BALB\/cJ and BALB\/cByJ substrains. Behav Genet 40:201\u2013210","journal-title":"Behav Genet"},{"issue":"21","key":"2140_CR40","first-page":"7","volume":"305","author":"X Zhang","year":"2004","unstructured":"Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG (2004) Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305(21):7","journal-title":"Science"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-010-2140-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-010-2140-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-010-2140-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:16:18Z","timestamp":1740788178000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-010-2140-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,22]]},"references-count":40,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["2140"],"URL":"https:\/\/doi.org\/10.1007\/s00213-010-2140-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,22]]}}}